Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2

Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2022-02, Vol.213, p.173338-173338, Article 173338
Hauptverfasser: D'Souza, Manoranjan S., Seeley, Sarah L., Emerson, Nathaniel, Rose-Malkamaki, Madison J., Ho, Sheng-Ping, Tsai, Yi-Chih, Kuo, Henry, Huan, Ching-Yu, Rorabaugh, Boyd R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 173338
container_issue
container_start_page 173338
container_title Pharmacology, biochemistry and behavior
container_volume 213
creator D'Souza, Manoranjan S.
Seeley, Sarah L.
Emerson, Nathaniel
Rose-Malkamaki, Madison J.
Ho, Sheng-Ping
Tsai, Yi-Chih
Kuo, Henry
Huan, Ching-Yu
Rorabaugh, Boyd R.
description Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above described effects of nicotine. Male and female mice lacking either RGS2 (RGS2 KO) or RGS4 (RGS4 KO), and their respective wildtype (WT) littermates were used in this study. The rewarding effects of nicotine (0.5 mg/kg, base; s.c.) were assessed using the conditioned place preference model. Nicotine-induced anxiolytic-like (0.1 mg/kg, base; i.p.) and antidepressant-like (1 mg/kg, base; i.p.) effects were assessed using the elevated plus maze and tail suspension test, respectively. We also assessed effects of nicotine (0, 0.05, 0.1 & 0.5 mg/kg, base; s.c.) on spontaneous locomotor activity. Nicotine-induced rewarding and antidepressant-like effects were observed in both male and female RGS2 WT mice, but not in mice lacking RGS2 compared to respective controls. In contrast, nicotine-induced rewarding and antidepressant-like effects were observed in both male and female mice lacking RGS4 and their WT littermates. Interestingly, deletion of RGS4 facilitated antidepressant-like effect of nicotine in male, but not female mice compared to respective WT littermates. Nicotine-induced anxiolytic-like effect was not influenced by deletion of either RGS2 or RGS4, irrespective of sex. Nicotine (0.5 mg/kg) decreased locomotor activity in both WT and KO mice compared to respective saline, irrespective of genotype and sex. Taken together, these data provide evidence that RGS2, but not RGS4, plays a role in mediating the rewarding and antidepressant-like effects of nicotine. Further research is required to explore the role of RGS2 after chronic exposure to nicotine. •Nicotine-induced rewarding effects were attenuated in mice lacking RGS2.•Nicotine-induced antidepressant-like effects were blocked in mice lacking RGS2.•Nicotine-induced rewarding effects were not affected in mice lacking RGS4.•Nicotine-induced antidepressant-like effects were facilitated in male mice lacking RGS4.
doi_str_mv 10.1016/j.pbb.2022.173338
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2621018767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009130572200017X</els_id><sourcerecordid>2621018767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-4df020b8ac9f6fabf2aba7236602b5c1b713ee7beb6a5a1c8936fcd260368ca73</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhAdigLNlk8E9iZ8SqqmiLVKmbsrau7euRp4kz2A6o78BD43QKyy4s38V3jq_PIeQjo1tGmfxy2B6N2XLK-ZYpIcTwimzYoETbM6Vekw2lO9YK2qsz8i7nA6W041K9JWeip2Loum5D_lyUgnGBEubYzL6Jwc4lRGxDdItF1yT8DcmFuG8gunpKcHhMmHMd2zE8YIPeoy25CbGZYMQnzuPTOAWLzQj2YdUn3C8jlDmt71y3xzQXrJoc9hHGFeDvyRsPY8YPz_c5-XH17f7ypr29u_5-eXHbWtGL0nbOU07NAHbnpQfjORhQXEhJuektM4oJRGXQSOiB2WEnpLeOSyrkYEGJc_L55Ft3-LlgLnoK2eI4QsR5yZpLXvMdlFxRdkJtmnNO6PUxhQnSo2ZUryXog64l6LUEfSqhaj492y9mQvdf8S_1Cnw9AVg_-Stg0tkGjDXukGqU2s3hBfu_RfaaKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621018767</pqid></control><display><type>article</type><title>Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>D'Souza, Manoranjan S. ; Seeley, Sarah L. ; Emerson, Nathaniel ; Rose-Malkamaki, Madison J. ; Ho, Sheng-Ping ; Tsai, Yi-Chih ; Kuo, Henry ; Huan, Ching-Yu ; Rorabaugh, Boyd R.</creator><creatorcontrib>D'Souza, Manoranjan S. ; Seeley, Sarah L. ; Emerson, Nathaniel ; Rose-Malkamaki, Madison J. ; Ho, Sheng-Ping ; Tsai, Yi-Chih ; Kuo, Henry ; Huan, Ching-Yu ; Rorabaugh, Boyd R.</creatorcontrib><description>Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above described effects of nicotine. Male and female mice lacking either RGS2 (RGS2 KO) or RGS4 (RGS4 KO), and their respective wildtype (WT) littermates were used in this study. The rewarding effects of nicotine (0.5 mg/kg, base; s.c.) were assessed using the conditioned place preference model. Nicotine-induced anxiolytic-like (0.1 mg/kg, base; i.p.) and antidepressant-like (1 mg/kg, base; i.p.) effects were assessed using the elevated plus maze and tail suspension test, respectively. We also assessed effects of nicotine (0, 0.05, 0.1 &amp; 0.5 mg/kg, base; s.c.) on spontaneous locomotor activity. Nicotine-induced rewarding and antidepressant-like effects were observed in both male and female RGS2 WT mice, but not in mice lacking RGS2 compared to respective controls. In contrast, nicotine-induced rewarding and antidepressant-like effects were observed in both male and female mice lacking RGS4 and their WT littermates. Interestingly, deletion of RGS4 facilitated antidepressant-like effect of nicotine in male, but not female mice compared to respective WT littermates. Nicotine-induced anxiolytic-like effect was not influenced by deletion of either RGS2 or RGS4, irrespective of sex. Nicotine (0.5 mg/kg) decreased locomotor activity in both WT and KO mice compared to respective saline, irrespective of genotype and sex. Taken together, these data provide evidence that RGS2, but not RGS4, plays a role in mediating the rewarding and antidepressant-like effects of nicotine. Further research is required to explore the role of RGS2 after chronic exposure to nicotine. •Nicotine-induced rewarding effects were attenuated in mice lacking RGS2.•Nicotine-induced antidepressant-like effects were blocked in mice lacking RGS2.•Nicotine-induced rewarding effects were not affected in mice lacking RGS4.•Nicotine-induced antidepressant-like effects were facilitated in male mice lacking RGS4.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/j.pbb.2022.173338</identifier><identifier>PMID: 35038444</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Anti-Anxiety Agents - pharmacology ; Antidepressive Agents - pharmacology ; Anxiety ; Anxiety - drug therapy ; Anxiety - metabolism ; Brain ; Conditioning, Psychological - drug effects ; Depression ; Depression - drug therapy ; Depression - metabolism ; Elevated Plus Maze Test ; Female ; Locomotion - drug effects ; Male ; Mice ; Nicotine - pharmacology ; Reward ; RGS ; RGS Proteins - metabolism ; Smoking</subject><ispartof>Pharmacology, biochemistry and behavior, 2022-02, Vol.213, p.173338-173338, Article 173338</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-4df020b8ac9f6fabf2aba7236602b5c1b713ee7beb6a5a1c8936fcd260368ca73</citedby><cites>FETCH-LOGICAL-c353t-4df020b8ac9f6fabf2aba7236602b5c1b713ee7beb6a5a1c8936fcd260368ca73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pbb.2022.173338$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35038444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D'Souza, Manoranjan S.</creatorcontrib><creatorcontrib>Seeley, Sarah L.</creatorcontrib><creatorcontrib>Emerson, Nathaniel</creatorcontrib><creatorcontrib>Rose-Malkamaki, Madison J.</creatorcontrib><creatorcontrib>Ho, Sheng-Ping</creatorcontrib><creatorcontrib>Tsai, Yi-Chih</creatorcontrib><creatorcontrib>Kuo, Henry</creatorcontrib><creatorcontrib>Huan, Ching-Yu</creatorcontrib><creatorcontrib>Rorabaugh, Boyd R.</creatorcontrib><title>Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above described effects of nicotine. Male and female mice lacking either RGS2 (RGS2 KO) or RGS4 (RGS4 KO), and their respective wildtype (WT) littermates were used in this study. The rewarding effects of nicotine (0.5 mg/kg, base; s.c.) were assessed using the conditioned place preference model. Nicotine-induced anxiolytic-like (0.1 mg/kg, base; i.p.) and antidepressant-like (1 mg/kg, base; i.p.) effects were assessed using the elevated plus maze and tail suspension test, respectively. We also assessed effects of nicotine (0, 0.05, 0.1 &amp; 0.5 mg/kg, base; s.c.) on spontaneous locomotor activity. Nicotine-induced rewarding and antidepressant-like effects were observed in both male and female RGS2 WT mice, but not in mice lacking RGS2 compared to respective controls. In contrast, nicotine-induced rewarding and antidepressant-like effects were observed in both male and female mice lacking RGS4 and their WT littermates. Interestingly, deletion of RGS4 facilitated antidepressant-like effect of nicotine in male, but not female mice compared to respective WT littermates. Nicotine-induced anxiolytic-like effect was not influenced by deletion of either RGS2 or RGS4, irrespective of sex. Nicotine (0.5 mg/kg) decreased locomotor activity in both WT and KO mice compared to respective saline, irrespective of genotype and sex. Taken together, these data provide evidence that RGS2, but not RGS4, plays a role in mediating the rewarding and antidepressant-like effects of nicotine. Further research is required to explore the role of RGS2 after chronic exposure to nicotine. •Nicotine-induced rewarding effects were attenuated in mice lacking RGS2.•Nicotine-induced antidepressant-like effects were blocked in mice lacking RGS2.•Nicotine-induced rewarding effects were not affected in mice lacking RGS4.•Nicotine-induced antidepressant-like effects were facilitated in male mice lacking RGS4.</description><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Anxiety</subject><subject>Anxiety - drug therapy</subject><subject>Anxiety - metabolism</subject><subject>Brain</subject><subject>Conditioning, Psychological - drug effects</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Depression - metabolism</subject><subject>Elevated Plus Maze Test</subject><subject>Female</subject><subject>Locomotion - drug effects</subject><subject>Male</subject><subject>Mice</subject><subject>Nicotine - pharmacology</subject><subject>Reward</subject><subject>RGS</subject><subject>RGS Proteins - metabolism</subject><subject>Smoking</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EokPhAdigLNlk8E9iZ8SqqmiLVKmbsrau7euRp4kz2A6o78BD43QKyy4s38V3jq_PIeQjo1tGmfxy2B6N2XLK-ZYpIcTwimzYoETbM6Vekw2lO9YK2qsz8i7nA6W041K9JWeip2Loum5D_lyUgnGBEubYzL6Jwc4lRGxDdItF1yT8DcmFuG8gunpKcHhMmHMd2zE8YIPeoy25CbGZYMQnzuPTOAWLzQj2YdUn3C8jlDmt71y3xzQXrJoc9hHGFeDvyRsPY8YPz_c5-XH17f7ypr29u_5-eXHbWtGL0nbOU07NAHbnpQfjORhQXEhJuektM4oJRGXQSOiB2WEnpLeOSyrkYEGJc_L55Ft3-LlgLnoK2eI4QsR5yZpLXvMdlFxRdkJtmnNO6PUxhQnSo2ZUryXog64l6LUEfSqhaj492y9mQvdf8S_1Cnw9AVg_-Stg0tkGjDXukGqU2s3hBfu_RfaaKw</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>D'Souza, Manoranjan S.</creator><creator>Seeley, Sarah L.</creator><creator>Emerson, Nathaniel</creator><creator>Rose-Malkamaki, Madison J.</creator><creator>Ho, Sheng-Ping</creator><creator>Tsai, Yi-Chih</creator><creator>Kuo, Henry</creator><creator>Huan, Ching-Yu</creator><creator>Rorabaugh, Boyd R.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202202</creationdate><title>Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2</title><author>D'Souza, Manoranjan S. ; Seeley, Sarah L. ; Emerson, Nathaniel ; Rose-Malkamaki, Madison J. ; Ho, Sheng-Ping ; Tsai, Yi-Chih ; Kuo, Henry ; Huan, Ching-Yu ; Rorabaugh, Boyd R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-4df020b8ac9f6fabf2aba7236602b5c1b713ee7beb6a5a1c8936fcd260368ca73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Anxiety</topic><topic>Anxiety - drug therapy</topic><topic>Anxiety - metabolism</topic><topic>Brain</topic><topic>Conditioning, Psychological - drug effects</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Depression - metabolism</topic><topic>Elevated Plus Maze Test</topic><topic>Female</topic><topic>Locomotion - drug effects</topic><topic>Male</topic><topic>Mice</topic><topic>Nicotine - pharmacology</topic><topic>Reward</topic><topic>RGS</topic><topic>RGS Proteins - metabolism</topic><topic>Smoking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>D'Souza, Manoranjan S.</creatorcontrib><creatorcontrib>Seeley, Sarah L.</creatorcontrib><creatorcontrib>Emerson, Nathaniel</creatorcontrib><creatorcontrib>Rose-Malkamaki, Madison J.</creatorcontrib><creatorcontrib>Ho, Sheng-Ping</creatorcontrib><creatorcontrib>Tsai, Yi-Chih</creatorcontrib><creatorcontrib>Kuo, Henry</creatorcontrib><creatorcontrib>Huan, Ching-Yu</creatorcontrib><creatorcontrib>Rorabaugh, Boyd R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D'Souza, Manoranjan S.</au><au>Seeley, Sarah L.</au><au>Emerson, Nathaniel</au><au>Rose-Malkamaki, Madison J.</au><au>Ho, Sheng-Ping</au><au>Tsai, Yi-Chih</au><au>Kuo, Henry</au><au>Huan, Ching-Yu</au><au>Rorabaugh, Boyd R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2022-02</date><risdate>2022</risdate><volume>213</volume><spage>173338</spage><epage>173338</epage><pages>173338-173338</pages><artnum>173338</artnum><issn>0091-3057</issn><eissn>1873-5177</eissn><abstract>Nicotine-induced rewarding and mood altering effects contribute to the continued use of nicotine and the subsequent development of nicotine dependence. The goal of this study was to assess the role of two specific regulators of G-protein signaling (RGS) proteins namely RGS2 and RGS4 in the above described effects of nicotine. Male and female mice lacking either RGS2 (RGS2 KO) or RGS4 (RGS4 KO), and their respective wildtype (WT) littermates were used in this study. The rewarding effects of nicotine (0.5 mg/kg, base; s.c.) were assessed using the conditioned place preference model. Nicotine-induced anxiolytic-like (0.1 mg/kg, base; i.p.) and antidepressant-like (1 mg/kg, base; i.p.) effects were assessed using the elevated plus maze and tail suspension test, respectively. We also assessed effects of nicotine (0, 0.05, 0.1 &amp; 0.5 mg/kg, base; s.c.) on spontaneous locomotor activity. Nicotine-induced rewarding and antidepressant-like effects were observed in both male and female RGS2 WT mice, but not in mice lacking RGS2 compared to respective controls. In contrast, nicotine-induced rewarding and antidepressant-like effects were observed in both male and female mice lacking RGS4 and their WT littermates. Interestingly, deletion of RGS4 facilitated antidepressant-like effect of nicotine in male, but not female mice compared to respective WT littermates. Nicotine-induced anxiolytic-like effect was not influenced by deletion of either RGS2 or RGS4, irrespective of sex. Nicotine (0.5 mg/kg) decreased locomotor activity in both WT and KO mice compared to respective saline, irrespective of genotype and sex. Taken together, these data provide evidence that RGS2, but not RGS4, plays a role in mediating the rewarding and antidepressant-like effects of nicotine. Further research is required to explore the role of RGS2 after chronic exposure to nicotine. •Nicotine-induced rewarding effects were attenuated in mice lacking RGS2.•Nicotine-induced antidepressant-like effects were blocked in mice lacking RGS2.•Nicotine-induced rewarding effects were not affected in mice lacking RGS4.•Nicotine-induced antidepressant-like effects were facilitated in male mice lacking RGS4.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35038444</pmid><doi>10.1016/j.pbb.2022.173338</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2022-02, Vol.213, p.173338-173338, Article 173338
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_2621018767
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Anti-Anxiety Agents - pharmacology
Antidepressive Agents - pharmacology
Anxiety
Anxiety - drug therapy
Anxiety - metabolism
Brain
Conditioning, Psychological - drug effects
Depression
Depression - drug therapy
Depression - metabolism
Elevated Plus Maze Test
Female
Locomotion - drug effects
Male
Mice
Nicotine - pharmacology
Reward
RGS
RGS Proteins - metabolism
Smoking
title Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A44%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attenuation%20of%20nicotine-induced%20rewarding%20and%20antidepressant-like%20effects%20in%20male%20and%20female%20mice%20lacking%20regulator%20of%20G-protein%20signaling%202&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=D'Souza,%20Manoranjan%20S.&rft.date=2022-02&rft.volume=213&rft.spage=173338&rft.epage=173338&rft.pages=173338-173338&rft.artnum=173338&rft.issn=0091-3057&rft.eissn=1873-5177&rft_id=info:doi/10.1016/j.pbb.2022.173338&rft_dat=%3Cproquest_cross%3E2621018767%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2621018767&rft_id=info:pmid/35038444&rft_els_id=S009130572200017X&rfr_iscdi=true